Page 9 - Under Paul News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Slayback Appoints Paul Campanelli to Board of Directors News provided by Share this article Share this article PRINCETON, N.J., Feb. 26, 2021 /PRNewswire/ Slayback Pharma LLC (the Company or Slayback ), a Princeton, NJ based specialty pharmaceutical company, announced today the appointment of Paul Campanelli to its Board of Directors. Paul is the Chairman of Endo Pharmaceuticals, and was, until recently, President and CEO of Endo Pharmaceuticals, where he led a turnaround focused on executing Endo s strategy to improve productivity, simplify their business, and increase the value of the company s US Branded, US Generics and international pharmaceutical assets. He transformed the company through investments in high-barrier, technically challenging generic products and specialty brands all with a laser focus on differentiated and intelligent product selection.

Paul campanelliAjay singhPrnewswire slayback pharmaBusiness development at drCompany or slaybackEndo pharmaceuticalsCompanies incReddy laboratories ltdChief executive officerPar pharmaceutical companiesUnder paulPar pharmaceuticalVice presidentBusiness developmentPar pharmaceuticalsSlayback pharma llc